DIL Ltd. Industry : (Pharmaceuticals)

Quick Glance
Listed on BSE
Website : http://www.dil.net
  • Market Cap 741Crores
  • Book Value 138
  • Face Value 5
  • Current Price 808.00
  • % Change -5.28
  • 52 week H/L 1,125/ 623
  • Stock P/E 20.77
  • Dividend Yield 0 %

Stock vs. Index

DIL
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
7.97 311.77 361.71 342.13 712.16

ROCE Vs RONW

ROCE
RONW

Price History


  • Start Date :
  • End Date :

You can view historic prices (Open,High,Low,Close) of the company for the range of days


Shareholding Pattern

collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Mar 17 Jun 17 Sep 17 Dec 17 Mar 18 Jun 18 Sep 18 Dec 18
Sales 1.35 1.84 2.83 3.08 4.57 4.53 4.85 4.90
Other Income 0.22 0.07 0.10 0.14 0.24 0.10 0.08 0.04
Operating Profit -3.24 -2.45 -0.86 -1.14 -5.11 0.38 -8.39 0.90
Interest 1.28 1.61 3.30 1.96 3.77 3.88 3.98 4.10
Depreciation 0.93 0.93 0.95 0.94 1.01 1.02 0.92 0.86
Taxation 0.09 0.00 0.00 0.00 0.69 0.00 0.00 0.00
Net Profit / Loss -5.31 -4.92 -5.00 -3.89 -10.34 -4.42 -13.20 -4.02

Annual Results

(All figures In Rs. Cr.) Mar 10 Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18
Sales 14.83 16.37 18.41 18.05 15.20 13.52 7.28 5.86 12.51
Other Income 0.92 0.30 0.11 0.01 0.06 0.00 0.00 0.52 0.38
Operating Profit 4.47 6.60 10.97 9.09 4.30 2.90 -5.65 -9.52 -9.38
Interest 0.03 0.07 0.07 0.21 0.05 0.03 1.77 7.10 10.63
Depreciation 1.13 1.17 1.71 2.25 2.25 1.82 1.80 3.45 3.83
Taxation 2.66 5.47 3.73 1.30 0.78 0.32 -0.08 0.33 0.69
Net Profit / Loss 7.65 21.77 14.68 5.34 1.42 0.73 -9.14 4.63 -24.15

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM -51.72% -40.21%
1 Years 18.75% 276.06%
2 Years 15.54% 170.46%
3 Years 35.35% NaN%
4 Years 32.48% 3.63%
5 Years 7.61% NaN%

Investor Returns

Type Ratio / % Date
Dividend
25.00
19 Sep 2018
Bonus
1:1
08 Aug 2018
Rights
1:6
03 Apr 1995
Split
10:5
08 Aug 2018

Announcements

Date Title
Feb 14, 2019 DIL - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 13, 2019 DIL - Publication Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2018
Feb 13, 2019 DIL - Intimation Of Investor Presentation For February 2019
collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
423.30
-3.94%
101,563.57
678.80 / 375.40
158.80
46.99
Cipla Ltd.
540.40
-0.44%
43,539.73
678.00 / 483.75
176.61
30.87
Divi's Laboratories Ltd.
1,623.70
-0.93%
43,104.13
1,697.65 / 981.05
223.18
49.15
Dr. Reddy's Laboratories Ltd.
2,556.90
-4.21%
42,460.10
2,875.00 / 1,888.00
757.05
44.85
Aurobindo Pharma Ltd.
722.85
-3.50%
42,352.33
830.00 / 527.05
199.36
17.48
Piramal Enterprises Ltd.
2,160.65
-2.10%
39,764.64
3,302.55 / 1,796.75
1,436.98
7.76
Biocon Ltd.
615.40
-4.59%
36,924.00
718.35 / 543.80
86.33
99.15
Lupin Ltd.
775.80
-4.32%
35,101.21
986.00 / 723.55
300.08
139.70
Cadila Healthcare Ltd.
314.00
-1.58%
32,145.52
432.40 / 306.35
85.42
18.10
Torrent Pharmaceuticals Ltd.
1,772.00
0.05%
29,986.27
1,960.00 / 1,223.75
273.14
44.22